Lead substances and their use as therapeutics
US6660835B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Dec 24, 1998 |
| Grant date | Dec 9, 2003 |
| Priority date | — |
| Expiry date | Dec 24, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to peptides, which are useful in treating Staphylococcus infections. More particularly, the inventive peptides interfere with the regulation of the agr system of Staphylococcus species, especially S. aureus, and thereby block the formation of different virulence factors. The inventive peptides comprise at least the amino acid sequence S V X A S Y F, whereby cyclic structures of that kind of peptides are the most potent blocking reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.